PATH | VRL
Menu

Safety and Immunogenicity of a Parenterally Administered Rotavirus VP8 Subunit Vaccine in Healthy Adults

This article, published in Vaccine, reports on a study to evaluate the safety and immunogenicity of a non-replicating rotavirus vaccine candidate. The authors found that the vaccine was well-tolerated in healthy adults and evoked promising immune responses.

Author: Fix AD, Harro C, McNeal M, et al.

Published: 2015

» Visit web page (English)

(Located at www.sciencedirect.com)

Citation: Fix AD, Harro C, McNeal M, et al. Safety and Immunogenicity of a Parenterally Administered Rotavirus VP8 Subunit Vaccine in Healthy Adults. Vaccine. 2015;33(31):3766-3772. 

Resource types: Peer-reviewed journal

Diseases/vaccines: Rotavirus

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: North America and Europe